GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration
Work
Year: 2024
Type: article
Abstract: At present, GPX4's role in the occurrence and development of diffuse large B lymphoma (DLBCL) is rarely reported. This study's purpose is to explore GPX4's significance in the diagnosis, treatment, an... more
Source: Heliyon
Cites: 38
Cited by: 5
Related to: 10
FWCI: 6.709
Citation percentile (by year/subfield): 99.99
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Zero hunger
Open Access status: gold
APC paid (est): $1,750